An intraocular implant that provides visual magnification to patients with moderate to profound central vision impairment due to advanced age-related macular degeneration.
Emerging Technology Reports
The Emerging Technology Report provides regular updates about emerging and potentially disruptive technologies that are likely to have a significant impact in healthcare. This “early warning” report monitors new health technologies from 6 months to 2 years within a regulatory submission and tracks those as they go through clinical trial development and the regulatory approval process.
For each emerging technology, our analysts describe the technology and intended use, its prospects relative to the regulatory process and FDA information, competing technologies, relevant clinical guidelines, high-level look at the evidence such as published abstracts in the medical literature and available meeting abstracts, and available clinical trials.
Myrbetriq™ (Mirabegron)
An oral β-3-adrenoreceptor agonist for the treatment of overactive bladder.
Belviq® (Lorcaserin)
An oral, selective, 5-HT2C receptor agonist to promote long-term weight management.
MEVION S250™ Proton Therapy System
A single-room proton therapy system with a gantry-mounted superconducting synchrocyclotron intended as an alternative to conventional large proton therapy systems.
Edwards Sapien® Transcatheter Heart Valve
A prosthetic heart valve for transcatheter aortic valve implantation.
PICO™ Negative Pressure Wound Therapy System
A single-use negative pressure wound therapy system for use in the hospital and at home for treatment of a variety of chronic, acute, traumatic, and surgical wounds.
CoreValve® Transcatheter Aortic Valve System
A self-expanding, prosthetic, aortic valve for percutaneous or trans-subclavian implantation, developed as an alternative to current care surgical aortic valve replacement in patients with severe aortic stenosis at a high or prohibitive risk for operative mortality.
Xgeva® (Denosumab) to Delay Onset of Bone Metastasis in Men with Nonmetastatic Castration-Resistant Prostate Cancer
A once-monthly injected biologic agent for prevention of bone metastases in men with nonmetastatic castration-resistant prostate cancer at high risk for rapid progress of disease to the bone.
mySentry™ Remote Glucose Monitor
A separately sold accessory used with the MiniMed Paradigm REAL-Time Revel system for within-the-home remote continuous glucose monitoring.
Antimicrobial Copper™ Surfaces for Infection Control
Copper and copper-based alloys intended to be used instead of existing building materials (e.g., stainless steel) for commonly touched hospital surfaces, such as door handles, bathroom fixtures, and other furnishings, as an antimicrobial measure in conjunction with standard infection control practices.